Status:
TERMINATED
The Effect of Ovamax on Oocyte Quality
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
Eugonia IVF Unit, Athens, Greece
Conditions:
Female
Infertility
Eligibility:
FEMALE
18-46 years
Phase:
NA
Brief Summary
Oocyte quality is a basic parameter that affects embryo quality and therefore it influences the outcome of assisted reproduction. It has been suggested that oocyte quality is improved by the intake of...
Detailed Description
Randomisation This study is a blind randomized control trial to evaluate the association between Ova-Max intake and the quality of oocytes retrieved after ovarian stimulation. Randomization will be p...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients less than 46 years of age
- ICSI for fertilisation to allow evaluation of oocyte quality
- Exclusion criteria:
- Women with endometriosis
- Women with only one ovary
- More than two previous IVF cycles
- Use of testicular sperm
- Intake of other dietary supplements
- Poor responders
Exclusion
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2025
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT06203223
Start Date
July 1 2021
End Date
January 15 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Papageorgiou Hospital
Thessaloniki, Central Macedonia, Greece, 54631